Artificial Intelligence-Assisted Hippocampal Segmentation and Its Diagnostic Value for Alzheimer's Disease: A Meta-analysis.
Journal:
Academic radiology
Published Date:
May 7, 2025
Abstract
BACKGROUND: Hippocampal atrophy is a key marker of Alzheimer's disease (AD) and mild cognitive impairment (MCI). Diverse artificial intelligence (AI) architectures for automated hippocampal segmentation have been increasingly reported in neuroimaging research. Different hippocampal automated segmentation methods can be of added value for the AD diagnostic work-up and treatment planning. This study aims to conduct a thorough meta-analysis to evaluate the segmentation accuracy and diagnostic performance of AI-assisted hippocampal segmentation in AD and MCI.
Authors
Keywords
No keywords available for this article.